BPLPHARMA1,560.00

Bharat Parenterals Limited

· Pharma & Health
₹ CrorePeersJENBURPHKPLMAKERSLNOVARTINDPARNAXLABSGRLSHUKRAPHARSUNLOC
View
In ₹ Crore except Per Share
12 Months Ending
FY22
31/03/2022
FY23
31/03/2023
Non-current Assets
+ Property, Plant & Equipment39.835.3
+ Capital Work-in-Progress0.60.0
+ Investment Property1.11.0
+ Non-current Investments4.838.4
+ Other Non-current Financial Assets26.157.1
+ Other Non-current Assets2.21.8
Current Assets
+ Inventories20.837.8
+ Current Investments11.50.0
+ Trade Receivables73.4112.4
+ Cash & Cash Equivalents3.36.4
+ Other Bank Balances1.31.1
+ Short-term Loans0.10.1
+ Other Current Financial Assets24.33.8
+ Other Current Assets8.713.0
Total Assets218.0308.0
Equity
+ Equity Share Capital5.85.8
+ Other Equity / Reserves160.4185.3
Total Equity166.2191.1
Liabilities
+ Deferred Tax Liabilities1.00.4
+ Borrowings — Current9.76.9
+ Trade Payables22.547.9
+ Other Current Financial Liab6.210.0
+ Provisions — Current0.91.3
+ Current Tax Liabilities0.90.5
+ Other Current Liabilities4.210.0
Total Equity & Liabilities218.0308.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY23 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.